• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Mumbai , Oct. 11

CHALLENGES facing the domestic drug industry, including the changing dynamics of the product patent regime that comes into force in 2005, will be deliberated at the two-day Pharma Summit 2004 that kicks off in Mumbai on Tuesday.

From projecting India as an integrated pharmaceutical hub to discussing global issues that impact the domestic drug industry, the conference will explore facing the industry.

Outlining them, Mr Habil Khorakiwala, Chairman of the summit, said: " The challenge before the country is not really regarding off-patent products. It is about how you manage administration of the cost of products that are being patented."

The summit is being organised by the CII and a host of pharmaceutical associations.

More Stories on : Pharmaceuticals | IPR

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Rain and snow in the North

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line